All Type of News
AZ to defend patents through alternation of salt, but Tribunal said ‘nothing for patent’
AstraZeneca applied for an appeal to the nullification of patents related to substance and more in Korea, it was not able to get the rights back. It is analyzed the AstraZeneca’s strategy to take a favorable position ...
Listed pharmaceuticals’ sales & management expense ratio continues to decrease
Listed pharmaceutical companies have actively working on cutting their sales & management expenses to increase profitability.
According to the Yakup Shinmoon’s(www.yakup.com) analysis result of the 2016 first half’s ...
Handok introduces Australia’s top nasal spray in Korea, expanding OTC businessThe Handok’s OTC business has started to bear fruits. Handok which acquired an arthritis treatment ‘Ketotop’ through acquiring Pacific Pharmaceuticals succeeded in acquiring the...
|
Multinational pharmaceuticals surprised by Novartis crisis, “Lawful academic supports should not be restricted”
As the prosecution’s Novartis rebate investigation which was conducted from last February was finalized with indictment of 34 people including its current and former executives without detention, other multinational p...
MSD plans to occupy cervical cancer vaccine market using ‘Gardasil9’Since cervical cancer vaccines will be included in the National Immunization Program(NIP) from this June, the private cervical cancer vaccine market is also expected to get enla...
|
Hospital pharmacists working on surveying multinational pharmaceuticals’ out-of-stock status
In order to solve multinational pharmaceutical companies’ frequent pharmaceutical out-of-stock status, pharmacists of each hospital started to investigate actual conditions in the field.
They plan to seek for counter...
Very ‘decent’ sales performances of listed pharmaceutical companies in first half
Listed pharmaceutical companies’ sales performances were evaluated as decent in the first half of the year.
Their sales growth rate was above 10%, their profit growth rate reached 30%, and their net profits were also...
Novartis’ incident cause anxiety among multinational companies
As a investigation result of rebates on Novartis Korea which records the top second sales among other multinational pharmaceutical companies branched in Korea, attention has bee focused on multinational pharmaceutical...
Pfizer announces approval of Ibrance is getting closerA targeted therapy for HER2 negative breast cancer is going to be introduced in Korea.
According to the industry concerned on the 16th, a Pfizer Pharmaceuticals Korea’s new br...
|
Sad story of the first generic independent from ‘authorized’ status
The first domestic generic which got independent from an authorized generic came out. However, a criticism has slowly been spread that contracts that are more advantageous to pharmaceutical companies owning original p...
